BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwak YK, Park HH, Choi KH, Park EY, Sung SY, Lee SW, Hong JH, Lee HC, Yoo IR, Kim YS. SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer. Cancer Res Treat 2020;52:85-97. [PMID: 31122008 DOI: 10.4143/crt.2019.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Han J, Song Q, Guo F, Du R, Fang H, Kang J, Lu Z. Evaluation of response to stereotactic body radiation therapy for nonsmall cell lung cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors. Nucl Med Commun 2022. [PMID: 35354781 DOI: 10.1097/MNM.0000000000001556] [Reference Citation Analysis]
2 Zhang R, Kang J, Ren S, Xing L, Xu Y. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Ann Transl Med 2022;10:104. [PMID: 35282118 DOI: 10.21037/atm-21-6256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Meng J, Deshayes E, Zhang L, Shi W, Zhang X, Chen X, Mei X, Ma J, Jiang Y, Wu J, Shao Z, Yu X, Yang Z, Guo X. Prognostic value of metabolic signature on 18F-FDG uptake in breast cancer patients after radiotherapy. Molecular Therapy - Oncolytics 2021;23:412-419. [DOI: 10.1016/j.omto.2021.10.008] [Reference Citation Analysis]
4 Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A, Ronchi S, Fiore MR, Paganelli C, Buizza G, Ciocca M, Baroni G, Preda L, Orlandi E. Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review. Br J Radiol 2021;94:20210524. [PMID: 34520670 DOI: 10.1259/bjr.20210524] [Reference Citation Analysis]
5 Huang YS, Chen JL, Chen HM, Yeh LH, Shih JY, Yen RF, Chang YC. Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer. BMC Cancer 2021;21:348. [PMID: 33794813 DOI: 10.1186/s12885-021-08064-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Infante J, Cabrera J, Rayo J, Cruz C, Serrano J, Moreno M, Martínez A, Jiménez P, Cobo A. 18F-FDG PET/CT quantitative parameters as prognostic factors in localized and inoperable lung cancer. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2020;39:353-9. [DOI: 10.1016/j.remnie.2020.09.001] [Reference Citation Analysis]
7 Infante JR, Cabrera J, Rayo JI, Cruz C, Serrano J, Moreno M, Martínez A, Jiménez P, Cobo A. 18F-FDG PET/CT quantitative parameters as prognostic factor in localized and inoperable lung cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2020;39:353-9. [PMID: 32605894 DOI: 10.1016/j.remn.2020.05.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]